EMA Highlights: Green light for new medicines
by Gary Finnegan: Eight new medicines have been approved by the European Medicines Agency at its summer meeting. The influential Committee for Medicinal Products for Human use (CHMP)… read more.
by Gary Finnegan: Eight new medicines have been approved by the European Medicines Agency at its summer meeting. The influential Committee for Medicinal Products for Human use (CHMP)… read more.
by Gary Finnegan: The European Medicines Agency (EMA) has restructured its staff in a bid to efficiently deal changing demand. The Agency faces the challenge of keeping up… read more.
by Gary Finnegan: Within hours of the UK’s vote to leave the European Union, at least half a dozen countries began to call for the European Medicines Agency… read more.
by Gary Finnegan: Six medicines, including two combination therapies for chronic hepatitis C, have been recommended for approval at the May meeting of the European Medicines Agency’s Committee… read more.
by Gary Finnegan: The EU drug watchdog is reviewing the guidelines on first-in-human clinical trials in response to the tragic death of a participant in a trial in… read more.
by Gary Finnegan: Most successful applicants to the EU drug watchdog, the European Medicines Agency, have something in common: they seek scientific advice from the regulator when developing… read more.
by Gary Finnegan: Cholesterol levels – the most common risk factor for heart attacks – have decreased in northern Sweden over the last 20 years. Since medication only… read more.
by Gary Finnegan: Researchers in Finland have used computer modelling to estimate the true impact of infectious diseases, such as H1N1 (swine flu). Underreporting of cases means traditional… read more.
by Gary Finnegan: Exposing migraine sufferers to a narrow band of green light significantly reduces light sensitivity and can reduce headache severity, according to a new study led… read more.
by Gary Finnegan: Hospital admissions for first-time stroke increased in young adults in Denmark during the past two decades, according to new research in Journal of the American… read more.
by Gary Finnegan: Cooperation between medicines regulators and health technology assessment (HTA) bodies is helping to streamline clinical studies of new medicines, according to a new report.
by Gary Finnegan: The European Medicines Agency (EMA) has published a draft version of a new paper on how to extrapolate clinical trial data from adults to children…. read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.